Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $2.7 million.

  • Prestige Consumer Healthcare's Share-based Compensation fell 439.79% to $2.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $10.9 million, marking a year-over-year decrease of 1012.26%. This contributed to the annual value of $11.2 million for FY2025, which is 2036.4% down from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Share-based Compensation of $2.7 million as of Q4 2025, which was down 439.79% from $1.8 million recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Share-based Compensation registered a high of $4.1 million during Q2 2023, and its lowest value of $1.7 million during Q1 2022.
  • For the 5-year period, Prestige Consumer Healthcare's Share-based Compensation averaged around $2.9 million, with its median value being $2.7 million (2025).
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Share-based Compensation skyrocketed by 10537.81% in 2022, and later crashed by 4213.67% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's Share-based Compensation (Quarter) stood at $2.2 million in 2021, then increased by 8.91% to $2.4 million in 2022, then grew by 0.66% to $2.4 million in 2023, then increased by 16.99% to $2.9 million in 2024, then dropped by 4.4% to $2.7 million in 2025.
  • Its Share-based Compensation was $2.7 million in Q4 2025, compared to $1.8 million in Q3 2025 and $3.7 million in Q2 2025.